WHERE ARE YOU?

Concept Pre-Sub Submission prep Newly cleared Raising Exit Postmarket & security

THE TAPE

MintNeuro raises 4.4 million euros for chips designed into neural implants iRhythm closes the VitalConnect deal at $287.5M, mostly in cash HeartSciences clears the MyoVista ECG hardware under K260005 without its AI algorithm FDA approves an Abbott update that shows CardioMEMS patients their own pressure readings UK accepts 44 AI commission recommendations and moves to continuous device monitoring Click Therapeutics clears Motivista for the negative symptoms of schizophrenia NeuWire Medical wins an IDE for a 135-patient trial of battery-free vagus nerve stimulation GE HealthCare pays $945M cash for Sofie Biosciences and 15 PET manufacturing sites Zenflow raises $52M and hands Cook Medical US distribution for the Spring implant MintNeuro raises 4.4 million euros for chips designed into neural implants iRhythm closes the VitalConnect deal at $287.5M, mostly in cash HeartSciences clears the MyoVista ECG hardware under K260005 without its AI algorithm FDA approves an Abbott update that shows CardioMEMS patients their own pressure readings UK accepts 44 AI commission recommendations and moves to continuous device monitoring Click Therapeutics clears Motivista for the negative symptoms of schizophrenia NeuWire Medical wins an IDE for a 135-patient trial of battery-free vagus nerve stimulation GE HealthCare pays $945M cash for Sofie Biosciences and 15 PET manufacturing sites Zenflow raises $52M and hands Cook Medical US distribution for the Spring implant

Acquisition

iRhythm closes the VitalConnect deal at $287.5M, mostly in cash

MedDevice Startups Staff · 1 day ago · 2 min read · Via MassDevice

iRhythm Technologies closed its acquisition of VitalConnect on October 6, two months after announcing it. The price was $287.5 million. Of that, $237.5 million came in cash off iRhythm's balance sheet, with about 423,334 iRhythm shares issued at closing.

VitalConnect sells a wearable patch platform for mobile cardiac telemetry and multi-vitals monitoring. iRhythm also put $10 million of working capital into the company between signing in August and the close. iRhythm says the deal leaves its 15 percent adjusted EBITDA margin target for 2027 intact.

For a monitoring company, the shape of this exit matters as much as the price. VitalConnect sold into a gap in iRhythm's line, cardiac telemetry and multi-vitals beyond the wearable patch, instead of competing with the patch directly.

Questions & Answers

How much did iRhythm pay for VitalConnect?

iRhythm Technologies paid $287.5 million for VitalConnect. The price was $237.5 million in cash plus about 423,334 iRhythm shares issued at the October 6, 2026 close.

What does VitalConnect make?

VitalConnect sells a wearable patch platform for mobile cardiac telemetry and multi-vitals monitoring. iRhythm Technologies acquired the company on October 6, 2026.

When did iRhythm announce the VitalConnect acquisition?

iRhythm Technologies announced the VitalConnect acquisition in August 2026 and closed it on October 6, 2026.

← Back to M&A